Blog
RSS FeedPosted by Michael Wonder on 11 Sep 2019
We need to make biosimilars easier to get
11 September 2019 - If potential biosimilar manufacturers can’t get their product to market, they won’t proceed with development. ...
Posted by Michael Wonder on 11 Sep 2019
Anti-depressant medicine brand switch: 'They've been used as guinea pigs'
11 September 2019 - Emotions ran high at the Health Select Committee today, with MPs grilling Medsafe and the Ministry ...
Posted by Michael Wonder on 10 Sep 2019
Drug formulary managers' use of step therapy can lead to sub-optimal outcomes
9 September 2019 - Over the past two decades the use of step therapy or edits by health insurers has ...
Posted by Michael Wonder on 10 Sep 2019
Erosion of physician and patient treatment choice continues - Alliance for Safe Biologic Medicines raises concerns for patients as British Columbia expands biologics forced switching policy
10 September 2019 - On 5 September, the Government of British Columbia announced that it would be forcibly switching 1,700 patients ...
Posted by Michael Wonder on 08 Sep 2019
'Barriers in place': access to asthma medication key to reducing deaths
8 September 2019 - High school teacher Gabriel Wenman admits she was once terrible at taking her asthma medication. ...
Posted by Michael Wonder on 02 Sep 2019
Biosimilars Forum’s public letter in response to anti-biosimilars Op-Ed
29 August 2019 - Government Should Not “Throw In the Towel on Biosimilars,” They Should Act Now to Unlock Billions ...
Posted by Michael Wonder on 02 Sep 2019
Dutch experience demonstrates effective benchmarking of biosimilar use in health systems
31 August 2019 - As medicines become more numerous and often more expensive, health care professionals seek new ways to understand ...
Posted by Michael Wonder on 01 Sep 2019
'No jab, no pay' threat prompts an extra 174,000 children to be vaccinated in one year
1 September 2019 - A threat to cut family tax benefits for Australians who did not vaccinate their children has ...
Posted by Michael Wonder on 27 Aug 2019
We need a more rational biosimilars policy
27 August 2019 - Throwing in the towel on a whole new category of medicines, just shy of a decade in, ...
Posted by Michael Wonder on 26 Aug 2019
Don’t give up on biosimilars—Congress can give them a boost
25 August 2019 - Drugs grown in live cells are hard to replicate. But policy changes can help accelerate the process. ...
Posted by Michael Wonder on 22 Aug 2019
Time to throw in the towel on biosimilars
21 August 2019 - A major reason drugs are even mildly affordable in the U.S. is that cheap generic copies ...
Posted by Michael Wonder on 17 Jul 2019
Majority of patients not asked for consent before being switched to a biosimilar, survey finds
17 July 2019 - The preliminary survey results showed that 52% of patients received a letter from hospital about switching to ...
Posted by Michael Wonder on 17 Jul 2019
Trump to order drive for improved flu vaccine
16 July 2019 - President Donald Trump is readying an executive order that would direct HHS to overhaul the development ...
Posted by Michael Wonder on 15 Jul 2019
Pharmaceutical Benefits Scheme restrictions on anti‐epileptic drug prescribing promote unsafe and outdated practice
1 July 2019 - The PBS urgently needs to update anti‐epileptic drug prescribing restrictions that put patients and prescribers at ...
Posted by Michael Wonder on 14 Jul 2019
Bev takes 14 pills a day. She's far from alone.
15 July 2019 - She is among the more than one-in-three Australians aged over 70 who take five or more different ...